LEUPRORELIN ACETATE, FULVESTRANT, ECI830, GOSERELIN, LEUPRORELIN ACETATE, GOSERELIN, RIBOCICLIB, ECI830, ECI830
CECI830A12101
Phase 2 small_molecule active
Quick answer
LEUPRORELIN ACETATE, FULVESTRANT, ECI830, GOSERELIN, LEUPRORELIN ACETATE, GOSERELIN, RIBOCICLIB, ECI830, ECI830 for Advanced solid tumors, Advanced HR+/HER2- breast cancer is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Advanced solid tumors, Advanced HR+/HER2- breast cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active